Globus Medical (GMED) said Thursday it has completed its all-cash $250 million acquisition of medical device company Nevro (NVRO).
The acquisition expands Globus Medical's footprint in the musculoskeletal market and unlocks a $2.5 billion market opportunity, the company said.
Nevro common stock ceased trading on the New York Stock Exchange before the market open on Thursday, Globus said.
Price: 72.15, Change: -3.35, Percent Change: -4.44
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。